The Board of Governors of L.A. Health Plan has unanimously given the green light to appoint Martha Santana-Chin as its next  CEO – making her the first female and Latina CEO to lead the organization, it said last week.

A group called Save Jennie Stuart has filed a lawsuit seeking to stop Deaconess Health’s planned acquisition of Jennie Stuart Medical Center in Hopkinsville, Kentucky.

If Congress doesn’t take action by the end of 2024 to make permanent waivers that have been extended for two years, the country goes back to March 2020 policy, says Tom Leary, senior vice president and head of government relations at HIMSS.  

Authorities have charged Luigi Mangione, 26, with the second-degree murder of UnitedHealthcare CEO Brian Thompson. Police arrested Mangione in Altoona, Pennsylvania Monday morning after a McDonald’s employee recognized him from photos circulating of the suspected killer and called local police.

Precision medicine’s genomic solutions were a great first step, but they are limited compared to AI’s ability – for example, Artera’s test for localized prostate cancer and recommended therapy, says CEO Andre Esteva.  

VoiceBot Grace does patient follow-up for discharges at home by setting up PCP appointments and this virtual assistant is part of the care team at Memorial Hermann, says Chief Digital Officer Eric Smith.  

GLP-1 drugs such as Ozempic and Wegovy have completely changed not only how physicians manage weight loss but how healthcare views obesity.

Yale New Haven Hospital is on track to complete the $838 million Adams Neurosciences Center at its Saint Raphael Campus and expects the project will be completed in 2027, the hospital said.

Although nearly all older Americans have Medicare coverage, they still pay more and are more likely to postpone or skip needed care because of costs than their counterparts in most other wealthy countries, according to new findings from the 2024 Commonwealth Fund International Health Policy Survey of Older Adults.

The American Heart Association, with initial funding from Bristol Myers Squibb, has launched a new three-year initiative to improve hypertrophic cardiomyopathy (HCM) systems of care and standardize how patients with HCM are identified, assessed, referred and treated.